Skip to main content
. 2020 Sep 16;4(2):rkaa041. doi: 10.1093/rap/rkaa041

Table 2.

Incremental increase in cost by RA duration and severity

Coefficient ME P-value Lower 95% CI Upper 95% CI
Cost model (€)
Disease duration 0.053 1075* 0.004 0.017 0.088
Change per unit increase in DAS28 0.157 360* 0.004 0.050 0.264
Age 0.005 NR 0.364 −0.006 0.017
Sex (female) −0.171 NR 0.268 −0.472 0.131
BMI −0.001 NR 0.967 −0.041 0.039
Constant 7.645 NR 0.000 6.740 8.550
Overall work impairment model (%)
Change per unit increase in DAS28 NR 4.7* 0.011 1.1 8.4
Mild vs no pain NR 33.3* 0.022 4.9 61.8
Moderate vs no pain NR 43.4* 0.004 13.6 73.2
Severe vs no pain NR 45.0* 0.009 11.2 78.9

Costs are formatted as follows: cost (subgroup sample size).

ME: marginal effect; NR: not reported.

*

P < 0.05.